▲ 4.13%
prev close
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Congressional Trades
10
All tracked trades
Members Trading
4
Unique members
Net Activity
+2
6 buys · 4 sells
Members Who Traded This Stock
10 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2026-09-09 | RVTYRevvity, Inc. Common Stock | Sell | $15,001 - $50,000 | 8d ago | — | |
| 2026-09-04 | RVTYRevvity, Inc. Common Stock | Sell | $1,001 - $15,000 | 8d ago | — | |
| 2026-09-03 | RVTYRevvity, Inc. Common Stock | Sell | $1,001 - $15,000 | 8d ago | — | |
| 2026-05-04 | RVTYRevvity, Inc. Common Stock | Buy | $15,001 - $50,000 | 134d ago | — | |
| 2026-05-01 | RVTYRevvity, Inc. Common Stock | Buy | $1,001 - $15,000 | 165d ago | — | |
| 2025-07-23 | RVTYRevvity, Inc. Common Stock | Buy | $1,001 - $15,000 | 432d ago | — | |
| 2025-06-17 | RVTYRevvity, Inc. Common Stock | Buy | $1,001 - $15,000 | 433d ago | — | |
| 2025-06-11 | RVTYRevvity, Inc. Common Stock | Buy | $1,001 - $15,000 | 467d ago | — | |
| 2025-02-28 | RVTYRevvity, Inc. Common Stock | Sell | $15,001 - $50,000 | 579d ago | — | |
| 2025-02-25 | RVTYRevvity, Inc. Common Stock | Buy | $1,001 - $15,000 | 572d ago | — |
2026-09-09
Gilbert Cisneros
RVTY
Amount
$15,001 - $50,000
Filed
8d ago
2026-09-04
Gilbert Cisneros
RVTY
Amount
$1,001 - $15,000
Filed
8d ago
2026-09-03
Gilbert Cisneros
RVTY
Amount
$1,001 - $15,000
Filed
8d ago
2026-05-04
Gilbert Cisneros
RVTY
Amount
$15,001 - $50,000
Filed
134d ago
2026-05-01
Gilbert Cisneros
RVTY
Amount
$1,001 - $15,000
Filed
165d ago
2025-07-23
Gilbert Cisneros
RVTY
Amount
$1,001 - $15,000
Filed
432d ago
2025-06-17
Lisa McClain
RVTY
Amount
$1,001 - $15,000
Filed
433d ago
2025-06-11
Gilbert Cisneros
RVTY
Amount
$1,001 - $15,000
Filed
467d ago
2025-02-28
April McClain Delaney
RVTY
Amount
$15,001 - $50,000
Filed
579d ago
2025-02-25
Rob Bresnahan
RVTY
Amount
$1,001 - $15,000
Filed
572d ago
Recent News
Powered by Polygon.io
Thermo Fisher to Report Q3 Earnings: What's in the Cards?
Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock?
North America Non-Viral Transfection Reagents Market Forecast to 2035 | Cell and Gene Therapy Demand Drives 8.5% CAGR and a USD 0.70 Billion Opportunity
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
Global Alzheimer’s Disease Biomarker Market Poised for Phenomenal Expansion at a Growth Rate of ~9% by 2034 | DelveInsight
Trade Timeline
Congressional activity, newest first
Gilbert Cisneros
2026-09-09 · Sale
$15,001 - $50,000
Gilbert Cisneros
2026-09-04 · Sale
$1,001 - $15,000
Gilbert Cisneros
2026-09-03 · Sale
$1,001 - $15,000
Gilbert Cisneros
2026-05-04 · Purchase
$15,001 - $50,000
Gilbert Cisneros
2026-05-01 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2025-07-23 · Purchase
$1,001 - $15,000
Lisa McClain
2025-06-17 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2025-06-11 · Purchase
$1,001 - $15,000
April McClain Delaney
2025-02-28 · Sale
$15,001 - $50,000
Rob Bresnahan
2025-02-25 · Purchase
$1,001 - $15,000